The economics of stratified medicine
- In: D8 - How patient stratification and pharmacogenetics affect ADRs in complex patients on Thursday, 5 September 2013, 14:00-17:00
- At: Dublin (Ireland) (2013)
- Type: Presentation
- By: REDEKOP, Ken (Erasmus University, Institute for Medical Technology Assessment, Rotterdam, Netherlands)
- Abstract:
..
Background
: Stratified medicine (SM) refers to the separation of a patient population into more homogeneous subgroups, with the overall aim of distinguishing between the patients likely to benefit from a treatment and the patients unlikely to benefit. SM can thereby increase the average treatment effectiveness (by filtering out non-responders) and The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress.
Please login
Last update 28 September 2023